...
【24h】

Midterm Outcomes After Arthroscopic Anteroinferior Capsular Release for the Treatment of Idiophatic Adhesive Capsulitis

机译:期中考试结果后关节镜下荚膜释放治疗Idiophatic胶囊炎

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The purpose of this study is to report the early and midterm functional outcomes and complications of a consecutive series of patients with primary adhesive capsulitis who were treated with isolated anteroinferior arthroscopic capsular release after they did not respond to conservative treatment. Methods: Thirty-two consecutive patients with idiopathic adhesive capsulitis who did not respond to conservative physiotherapy were included in the study. Arthroscopic anteroinferior capsular release was performed in all cases. The primary outcome was improvement in range of motion in the short-and midterm follow-up. We also evaluated pain relief with the visual analog scale, functional outcomes with the Constante-Murley score, and we registered postoperative complications. Results: The mean age was 49.6 years (range, 33-68 years) and the mean follow-up was 63 months (range, 18-84). Overall, there was significant improvement in the Constante-Murley score from 42.4 to 86 points (P < .001). The visual analog scale decreased by approximately 6.3 points compared with the preoperative value (P < .001). All parameters improved significantly the first 6 months and then remained stable until the end of follow-up (P < .001). There was an additional minor improvement in both parameters between the sixth month and the final follow-up; however, this improvement was less than in the first 6 months and it was not statistically significant. Conclusions: In patients who don't respond to conservative treatment for primary adhesive capsulitis, isolated anteroinferior capsular release provides a reliable improvement in pain and range of motion that is maintained in the mid-term follow-up. Level of Evidence: Level IV, therapeutic, case series study.
机译:目的:本研究的目的是报告早期和中期的功能结果一系列连续的并发症患者与主胶囊炎治疗与孤立的下关节镜荚膜释放后没有回应保守治疗。连续特发性患者胶粘剂囊炎谁没有回应保守理疗包括在这项研究中。关节镜下荚膜释放在所有情况下执行。改善的运动范围的时候中期随访。与视觉模拟尺度、功能结果Constante-Murley得分,我们注册的术后并发症。的平均年龄为49.6岁(范围、33 - 68年)平均随访63个月(范围,18 - 84)。改善Constante-Murley得分86分(P < 42.4措施)。规模下降了大约6.3与术前相比值(P <措施)。所有参数明显改善第一个6月,然后保持稳定,直到年底后续(P <措施)。在这两个参数之间的小改进第六个月,最后的随访;这个改进是小于第一个6个月,不具有统计学意义。结论:在患者不回应保守治疗主要粘合剂囊炎,孤立的下荚膜发布提供了一个可靠的改善疼痛维护和延展性中期随访。治疗病例系列研究。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号